SCHEMBL2575471

SCHEMBL2575471

CCOC(=O)c1[nH]cc(CC)c1N

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 6/20 0.46
KDM4E B2RXH2 4/20 0.46
GAA P10253 4/20 0.46
SMN1; SMN2 Q16637 4/20 0.46
MAPT P10636 3/20 0.46
NPC1 O15118 2/20 0.46
TP53 P04637 2/20 0.46
RAB9A P51151 2/20 0.46
HPGD P15428 4/20 0.45
HTT P42858 1/20 0.45
RECQL P46063 1/20 0.45
NPSR1 Q6W5P4 1/20 0.44
LMNA P02545 3/20 0.43
CYP1A2 P05177 2/20 0.43
CYP2C9 P11712 1/20 0.43
CYP2C19 P33261 1/20 0.43
CYP3A4 P08684 1/20 0.43
MAOA P21397 1/20 0.43
MEN1 O00255 2/20 0.41
KMT2A Q03164 2/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6065416 0.85 KDM4E (0.40) ALDH1A1KDM4EGAASMN1; SMN2MAPT
Hydrochloric Acid SCHEMBL28896491 0.85 ALDH1A1 (0.40) ALDH1A1KDM4EGAASMN1; SMN2MAPT
SCHEMBL2576551 0.84 ALDH1A1 (0.47) ALDH1A1KDM4EGAASMN1; SMN2MAPT
SCHEMBL1493615 0.83 ALDH1A1 (0.49) ALDH1A1KDM4EGAASMN1; SMN2MAPT
SCHEMBL11649335 0.82 CYP1A2 (0.50) ALDH1A1KDM4ESMN1; SMN2MAPTNPC1
SCHEMBL1536747 0.81 ALDH1A1 (0.44) ALDH1A1KDM4EGAASMN1; SMN2MAPT
SCHEMBL1650715 0.81 CYP1A2 (0.49) ALDH1A1KDM4EGAASMN1; SMN2MAPT
SCHEMBL31690279 0.80 ALDH1A1 (0.56) ALDH1A1KDM4EGAASMN1; SMN2MAPT
Hydrochloric Acid SCHEMBL28896540 0.79 ALDH1A1 (0.55) ALDH1A1KDM4EGAASMN1; SMN2MAPT
SCHEMBL17221655 0.78 KDM4E (0.48) ALDH1A1KDM4EGAASMN1; SMN2MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2382218-A1 DELTA-5-DESATURASE INHIBITORS Takeda Pharmaceutical Company Limited (JP) 2011-11-02 EP disclosed
WO-2010087467-A1 DELTA-5-DESATURASE INHIBITORS TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) 2010-08-05 WO disclosed
US-20100190747-A1 Fused ring compound and use thereof TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) 2010-07-29 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100190747-A1 Fused ring compound and use thereof CYP46A1, LTB4R2, PTGES ALDH1A1 875/4885KDM4E 2686/4885GAA 3631/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.